Press Releases for: H2 Antagonists

www.visiongainintelligence.com

`The GI market recently entered a crucial phase, with mounting commercial pressures affecting

San Francisco, CA and London, UK; 11 January 2006: The purpose of this visiongain report is to examine the prospects of the world gastrointestinal market. The gastrointestinal (GI) disorders market is one of the largest and most important in the ... ... Read More

This press release is about: gastrointestinal disorders, pharmaceutical revenue, irritable bowel syndrome, heartburn, crohn, s disease, ulcerative colitis, peptic ulcer, proton pump inhibitors, h2 antagonists, market analysis

Published: 2006-02-01